Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.

Journal of Alzheimer's disease : JAD2009Cao C, Cirrito JR, Lin X, et al.

Study designOther primary literature

SubjectHuman & animal

Record checks

Study design: Other primary literature
Subject: Human & animal
Publication year: 2009
Source: doi.org
Abstract display: Not reproduced here
Publication status: Corrected
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Publication-status notice

Publication status: Corrected

Europe PMC relationship metadata: corrected_by.

View status evidence →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Age FactorsAlzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnalysis of VarianceAnimalsBrainCaffeineCentral Nervous System StimulantsCognitionCytokinesDisease Models, AnimalDose-Response Relationship, DrugDrug Administration ScheduleHumansMaze LearningMiceMice, TransgenicMicrodialysisPhosphodiesterase InhibitorsPlasmaPresenilin-1TheophyllineTime Factors

DOI 10.3233/jad-2009-1071

PMID 19581723

View source →